GGrantIndex
← Leaderboards

Gene D Morse

State University Of New York At Buffalo

$10,749,384
Attributed
$12,423,889
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,423,889 · 7

By mechanism

D43$6,739,973 · 3
R01$2,868,969 · 1
N01$2,789,655 · 1
P41$25,292 · 2

Most similar at State University Of New York At Buffalo

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsTrainingResearch PersonnelUniversitiesEducational CurriculumFundingTraining ProgramsResearch TrainingBuffaloesSkillsPostdoctoral FellowClinical PharmacologyFacultyLaboratoriesMentorsZimbabweScientistAreaPharmacologyInternationalResearch Project GrantsDrug KineticsCollaborationsInnovation

Grant awards (43)

Global Infectious Diseases Research Training Program$295,469
D43 · FY2025 · TW · contact PI
HIV Clinical Pharmacology & Therapeutics Research Training Program$284,846
D43 · FY2025 · TW · contact PI
Global Infectious Diseases Research Training Program$298,072
D43 · FY2024 · TW · contact PI
HIV Clinical Pharmacology & Therapeutics Research Training Program$287,733
D43 · FY2024 · TW · contact PI
Global Infectious Diseases Research Training Program$299,098
D43 · FY2023 · TW · contact PI
HIV Clinical Pharmacology & Therapeutics Research Training Program$213,906
D43 · FY2023 · TW · contact PI
Exploration of Cloud Solutions to Enhance Global Infectious Diseases Research Training Program Activities$163,791
D43 · FY2023 · TW · contact PI
HIV Clinical Pharmacology & Therapeutics Research Training Program$281,953
D43 · FY2022 · TW · contact PI
Global Infectious Diseases Research Training Program$197,136
D43 · FY2022 · TW · contact PI
Global Infectious Diseases Research Training Program$233,521
D43 · FY2021 · TW · contact PI
Global Infectious Diseases Research Training Program$229,176
D43 · FY2020 · TW · contact PI
HIV Research Training Program$199,239
D43 · FY2020 · TW · contact PI
HIV Research Training Program$293,451
D43 · FY2019 · TW · contact PI
HIV Research Training Program$231,491
D43 · FY2019 · TW · contact PI
Global Infectious Diseases Research Training Program$213,340
D43 · FY2019 · TW · contact PI
Global Infectious Diseases Research Training Program$9,299
D43 · FY2019 · TW · contact PI
HIV Research Training Program$360,409
D43 · FY2018 · TW · contact PI
Global Infectious Diseases Research Training Program$243,181
D43 · FY2018 · TW · contact PI
HIV Research Training Program$251,374
D43 · FY2017 · TW · contact PI
Administrative Supplement: HIV Research Training Program$145,446
D43 · FY2017 · TW · contact PI
HIV Research Training Program$71,651
D43 · FY2017 · TW · contact PI
HIV Research Training Program$29,871
D43 · FY2017 · TW · contact PI
HIV Research Training Program$301,602
D43 · FY2016 · TW · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$53,892
D43 · FY2015 · TW · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$293,488
D43 · FY2013 · TW · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$299,981
D43 · FY2012 · TW · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$300,119
D43 · FY2011 · TW · contact PI
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL$2,389,410
N01 · FY2010 · AI · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$314,119
D43 · FY2010 · TW · contact PI
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL$400,245
N01 · FY2009 · AI · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$300,119
D43 · FY2009 · TW · contact PI
Antiretroviral Pharmacology Training in Resource Poor Countries$43,200
D43 · FY2009 · TW · contact PI
TDM & Drug Interactions in HIVinfected Substance Abusers$61,287
R01 · FY2007 · DA · contact PI
AMPRENAVIR AND EFAVIRENZ PHARMACOKINETICS BEFORE AND AFTER THE ADDITION OF$11,368
P41 · FY2007 · RR · contact PI
TDM & Drug Interactions in HIVinfected Substance Abusers$767,800
R01 · FY2006 · DA · contact PI
TDM & Drug Interactions in HIVinfected Substance Abusers$44,380
R01 · FY2006 · DA · contact PI
AMPRENAVIR AND EFAVIRENZ PHARMACOKINETICS BEFORE AND AFTER THE ADDITION OF$13,924
P41 · FY2006 · RR · contact PI
TDM & Drug Interactions in HIVinfected Substance Abusers$8,100
R01 · FY2006 · DA · contact PI
TDM &Drug Interactions in HIVinfected Substance Abusers$552,383
R01 · FY2005 · DA
TDM &Drug Interactions in HIVinfected Substance Abusers$132,818
R01 · FY2005 · DA
TDM &Drug Interactions in HIVinfected Substance Abusers$102,250
R01 · FY2005 · DA
TDM &Drug Interactions in HIVinfected Substance Abusers$568,694
R01 · FY2004 · DA
TDM &Drug Interactions in HIVinfected Substance Abusers$631,257
R01 · FY2003 · DA